| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 343.29B | 330.96B | 324.92B | 327.20B | 371.12B | 183.56B |
| Gross Profit | 139.55B | 133.67B | 129.72B | 131.43B | 144.44B | 72.96B |
| EBITDA | 29.41B | 29.90B | 29.04B | 30.50B | 42.85B | 21.41B |
| Net Income | 9.53B | 10.13B | 9.13B | 9.66B | 16.39B | 8.72B |
Balance Sheet | ||||||
| Total Assets | 353.68B | 334.64B | 350.72B | 361.93B | 371.77B | 353.38B |
| Cash, Cash Equivalents and Short-Term Investments | 25.32B | 18.05B | 18.32B | 23.83B | 30.36B | 25.61B |
| Total Debt | 122.43B | 121.61B | 154.36B | 161.78B | 173.30B | 172.92B |
| Total Liabilities | 227.70B | 213.17B | 233.91B | 245.35B | 264.36B | 262.32B |
| Stockholders Equity | 125.33B | 120.86B | 116.28B | 105.10B | 96.81B | 81.32B |
Cash Flow | ||||||
| Free Cash Flow | 592.50M | 14.98B | 2.17B | 1.96B | -11.38B | -19.00M |
| Operating Cash Flow | 6.14B | 31.01B | 16.79B | 20.50B | 27.96B | 6.53B |
| Investing Cash Flow | 1.24B | 5.09B | -6.95B | -13.12B | -19.55B | -97.55B |
| Financing Cash Flow | -3.80B | -36.39B | -15.37B | -13.96B | -3.68B | 96.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥1.51T | 11.88 | 9.29% | 1.11% | ― | ― | |
67 Neutral | ¥112.24B | 21.46 | ― | 2.08% | 5.33% | 13.54% | |
66 Neutral | ¥298.54B | 14.98 | 11.17% | 2.61% | 5.63% | 25.64% | |
64 Neutral | ¥457.48B | 9.24 | 4.18% | 2.57% | 1.26% | 14.65% | |
62 Neutral | ¥882.28B | 38.31 | 28.71% | 1.03% | 14.16% | 26.13% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥264.22B | 19.39 | ― | 2.72% | 2.23% | 57.10% |